
Opinion|Videos|September 11, 2024
Final Thoughts on Advancing Hepatic Encephalopathy (HE) Management
The panel emphasizes the need for alignment and collaboration to enhance outcomes in hepatic encephalopathy (HE), stressing the importance of implementation science, APP education, and proactive screening for chronic liver disease and cirrhosis. They advocate for interdisciplinary meetings to optimize patient care and medication management, highlighting the increasing prevalence of complications related to cirrhosis in the US.
Advertisement
Episodes in this series

This series was supported by Salix Pharmaceuticals.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
2
Patients With CKD Are Less Likely to Receive Adjuvant Chemotherapy
3
Obstructive Sleep Apnea Identified as Potential Risk Factor for Parkinson Disease
4
ICYMI: Highlights From ESMO 2025
5



































